Article

Preservation of positional identity in fetus-derived neural stem (NS) cells from different mouse central nervous system compartments.

Department of Pharmacological Sciences and Center for Stem Cell Research, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.
Cellular and Molecular Life Sciences CMLS (impact factor: 6.57). 10/2010; 68(10):1769-83. DOI:10.1007/s00018-010-0548-7 pp.1769-83
Source: PubMed

ABSTRACT Neural stem (NS) cells are a self-renewing population of symmetrically dividing multipotent radial glia-like stem cells, characterized by homogeneous expansion in monolayer. Here we report that fetal NS cells isolated from different regions of the developing mouse nervous system behave in a similar manner with respect to self-renewal and neuropotency, but exhibit distinct positional identities. For example, NS cells from the neocortex maintain the expression of anterior transcription factors, including Otx2 and Foxg1, while Hoxb4 and Hoxb9 are uniquely found in spinal cord-derived NS cells. This molecular signature was stable for over 20 passages and was strictly linked to the developmental stage of the donor, because only NS cells derived from E14.5 cortex, and not those derived from E12.5 cortex, carried a consistent transcription factor profile. We also showed that traits of this positional code are maintained during neuronal differentiation, leading to the generation of electrophysiologically active neurons, even if they do not acquire a complete neurochemical identity.

0 0
 · 
0 Bookmarks
 · 
36 Views
  • Article: The matrix metalloproteinase inhibitor Marimastat promotes neural progenitor cell differentiation into neurons by gelatinase independent TIMP-2- dependent mechanisms.
    [show abstract] [hide abstract]
    ABSTRACT: Metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs), produced in the brain by cells of non-neural and neural origin, including neural progenitors (NPs), are emerging as regulators of nervous system development and adult brain functions. In the present study we explored whether MMP-2, MMP-9 and TIMP-2, abundantly produced in the brain, modulate NP developmental properties. We found that treatment of NPs, isolated from murine fetal cerebral cortex or adult subventricular zone, with the clinically tested broad-spectrum MMP inhibitor Marimastat profoundly affected NP differentiation fate. Marimastat treatment allowed for an enrichment of our cultures in neuronal cells, inducing NPs to generate higher percentage of neurons and a lower percentage of astrocytes, possibly affecting NP commitment. Consistently with its pro-neurogenic effect, Marimastat early down-regulated the expression of Notch target genes, such as HES1 and HES5. MMP-2 and MMP-9 profiling on proliferating and differentiating NPs revealed that MMP-9 was not expressed under these conditions, whereas MMP-2 increased in the medium as proMMP-2 (72 kDa) during differentiation; its active form (62 kDa) was not detectable by gel zymography. MMP-2 silencing or administration of recombinant active MMP-2 demonstrated that MMP-2 does not affect NP neuronal differentiation, nor it is involved in Marimastat pro-neurogenic effect. We also found that TIMP-2 is expressed in NPs and increases during late differentiation, mainly as a consequence of astrocyte generation. Endogenous TIMP-2 did not modulate NP neurogenic potential; however the pro-neurogenic action of Marimastat was mediated by TIMP-2, as demonstrated by silencing experiments. In conclusion our data exclude a major involvement of MMP-2 and MMP-9 in the regulation of basal NP differentiation, but highlight the ability of TIMP-2 to act as key effector of the pro-neurogenic response to an inducing stimulus such as Marimastat.
    Stem cells and development 10/2012; · 4.15 Impact Factor

Marco Onorati